Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of August 2026

  1. Amgen

    World Rank (Aug-2026)
    83
    Market Cap (Aug-2026)
    224.092 Billion USD
    World Rank (Jan-05-2024)
    73
    Market Cap (Jan-05-2024)
    162.250 Billion USD
    World Rank (Jul-30-2023)
    105
    Market Cap (Jul-30-2023)
    126.300 Billion USD
    World Rank (Dec-25-2022)
    80
    Market Cap (Dec-25-2022)
    140.820 Billion USD
    World Rank (Jan-07-2022)
    113
    Market Cap (Jan-07-2022)
    128.03 Billion USD
    Annual Revenue in USD
    36,751 Million USD
    Annual Operating Income in USD
    9,080 Million USD
    Annual Net Income in USD
    7,711 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Company Profile

    Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 25,200 employees as on 2022. Headquarters is in California, USA.

    Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

    Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

    Facts About Company

    As on 2022, Amgen has 25,200 employees.

    Amgen annual revenue generated for period ending Dec-2022 was 26,323 million USD.

    Amgen annual net income generated for period ending Dec-2022 was 6,552 million USD.

    Amgen annual revenue generated for period ending Dec-2021 was 25,979 million USD.

    Split of Annual Revenue by business segment for period ending Dec-2021:

  2. Novo Nordisk A/S

    World Rank (Aug-2026)
    97
    Market Cap (Aug-2026)
    203.198 Billion USD
    World Rank (Jan-05-2024)
    16
    Market Cap (Jan-05-2024)
    459.394 Billion USD
    World Rank (Jul-30-2023)
    24
    Market Cap (Jul-30-2023)
    356.920 Billion USD
    World Rank (Dec-25-2022)
    27
    Market Cap (Dec-25-2022)
    301.520 Billion USD
    World Rank (Jan-07-2022)
    50
    Market Cap (Jan-07-2022)
    231.35 Billion USD
    Annual Revenue in USD
    33,748 Million USD
    Annual Operating Income in USD
    14,904 Million USD
    Annual Net Income in USD
    12,159 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Novo Nordisk is Denmark based Multinational Pharmaceutical Company. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Headquarters is in Denmark.

    Novo Nordisk employs approximately 55,185 employees in 79 countries as on 2022 and markets its products in more than 170 countries.

    Facts About Company

    For year ending December-2022, Novo Nordisk Annual Revenue was 176,954 Million DKK and Net Income was 55,525 Million DKK.

    For year ending December-2021, Novo Nordisk Annual Revenue was 140,800 Million DKK and Net Income was 47,757 Million DKK.

  3. Gilead Sciences

    World Rank (Aug-2026)
    127
    Market Cap (Aug-2026)
    171.560 Billion USD
    World Rank (Jan-05-2024)
    133
    Market Cap (Jan-05-2024)
    105.265 Billion USD
    World Rank (Jul-30-2023)
    154
    Market Cap (Jul-30-2023)
    95.871 Billion USD
    World Rank (Dec-25-2022)
    120
    Market Cap (Dec-25-2022)
    106.300 Billion USD
    World Rank (Jan-07-2022)
    180
    Market Cap (Jan-07-2022)
    89.39 Billion USD
    Annual Revenue in USD
    29,443 Million USD
    Annual Operating Income in USD
    10,022 Million USD
    Annual Net Income in USD
    8,510 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    GILEAD SCIENCES INC is world’s largest bio-pharmaceutical companies. As on Dec-2021, Gilead Sciences had 14,400 employees across six continents and headquarters is in USA,

    As on 2022, GILEAD SCIENCES INC has 17,000 employees.

    GILEAD SCIENCES INC annual revenue generated for period ending Dec-2022 was 27,281 million USD.

    GILEAD SCIENCES INC annual net loss generated for period ending Dec-2022 was 4,592 million USD.

  4. Argenx SE

    World Rank (Aug-2026)
    483
    Market Cap (Aug-2026)
    52.834 Billion USD
    World Rank (Jan-05-2024)
    802
    Market Cap (Jan-05-2024)
    22.967 Billion USD
    World Rank (Jul-30-2023)
    621
    Market Cap (Jul-30-2023)
    30.537 Billion USD
    World Rank (Dec-25-2022)
    799
    Market Cap (Dec-25-2022)
    20.875 Billion USD
    World Rank (Jan-07-2022)
    1,257
    Market Cap (Jan-07-2022)
    16.13 Billion USD
    Annual Revenue in USD
    410 Million USD
    Annual Operating Income in USD
    -719 Million USD
    Annual Net Income in USD
    -709 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Company Profile

    Biopharmaceutical company with headquarters is in Netherlands.

  5. Seagen

    World Rank (Aug-2026)
    515
    World Rank (Jan-05-2024)
    515
    World Rank (Jul-30-2023)
    515
    Market Cap (Jul-30-2023)
    36.021 Billion USD
    World Rank (Dec-25-2022)
    714
    Market Cap (Dec-25-2022)
    23.583 Billion USD
    World Rank (Jan-07-2022)
    804
    Market Cap (Jan-07-2022)
    26.28 Billion USD
    Annual Revenue in USD
    1,962 Million USD
    Annual Operating Income in USD
    -613 Million USD
    Annual Net Income in USD
    -610 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    Company Profile

    SEAGEN is Biotechnology company with headquarters is in Washington, USA.

    Pfizer acquired Seagen for 43 billion USD in 2023. Seagen manufactures Cancer drugs.

    As on 2022, SEAGEN has 3,256 employees.

    SEAGEN annual revenue generated for period ending Dec-2022 was 1,962 million USD.

    SEAGEN annual net loss generated for period ending Dec-2022 was -610 (Loss) million USD.

  6. Revolution Medicines Inc.

    World Rank (Aug-2026)
    597
    Market Cap (Aug-2026)
    43.662 Billion USD
    World Rank (Jan-05-2024)
    3,149
    Market Cap (Jan-05-2024)
    4.591 Billion USD
    World Rank (Jul-30-2023)
    4,655
    Market Cap (Jul-30-2023)
    2.733 Billion USD
    World Rank (Dec-25-2022)
    5,525
    Market Cap (Dec-25-2022)
    1.957 Billion USD
    World Rank (Jan-07-2022)
    6,958
    Market Cap (Jan-07-2022)
    1.69 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -1,182 Million USD
    Annual Net Income in USD
    -1,131 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Oncology therapies developing company with headquarters is in USA.
  7. Biogen

    World Rank (Aug-2026)
    844
    Market Cap (Aug-2026)
    31.003 Billion USD
    World Rank (Jan-05-2024)
    473
    Market Cap (Jan-05-2024)
    38.171 Billion USD
    World Rank (Jul-30-2023)
    470
    Market Cap (Jul-30-2023)
    38.390 Billion USD
    World Rank (Dec-25-2022)
    405
    Market Cap (Dec-25-2022)
    40.199 Billion USD
    World Rank (Jan-07-2022)
    609
    Market Cap (Jan-07-2022)
    34.17 Billion USD
    Annual Revenue in USD
    9,891 Million USD
    Annual Net Income in USD
    1,293 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Biogen INC is USA based Bio-Technology Company and they are pioneers in neuroscience medical science. Headquarters is in Massachusetts, USA.

  8. Moderna

    World Rank (Aug-2026)
    1,016
    Market Cap (Aug-2026)
    25.280 Billion USD
    World Rank (Jan-05-2024)
    436
    Market Cap (Jan-05-2024)
    41.430 Billion USD
    World Rank (Jul-30-2023)
    397
    Market Cap (Jul-30-2023)
    45.234 Billion USD
    World Rank (Dec-25-2022)
    174
    Market Cap (Dec-25-2022)
    76.483 Billion USD
    World Rank (Jan-07-2022)
    188
    Market Cap (Jan-07-2022)
    86.71 Billion USD
    Annual Revenue in USD
    1,944 Million USD
    Annual Operating Income in USD
    -3,074 Million USD
    Annual Net Income in USD
    -2,822 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Moderna is Biotechnology sector company with headquarters is in Massachusetts, USA. It has done good work on Covid-19 vaccine.

    As on 2022, Moderna has 3,900 employees.

    Moderna annual revenue generated for period ending Dec-2022 was 18.87 billion USD.

    Moderna annual net income generated for period ending Dec-2022 was 8.36 billion USD.

    Moderna annual revenue generated for period ending Dec-2021 was 16,471 million USD.

  9. BioNTech SE

    World Rank (Aug-2026)
    1,088
    Market Cap (Aug-2026)
    23.385 Billion USD
    World Rank (Jan-05-2024)
    686
    Market Cap (Jan-05-2024)
    26.909 Billion USD
    World Rank (Jul-30-2023)
    725
    Market Cap (Jul-30-2023)
    25.887 Billion USD
    World Rank (Dec-25-2022)
    380
    Market Cap (Dec-25-2022)
    42.705 Billion USD
    World Rank (Jan-07-2022)
    369
    Market Cap (Jan-07-2022)
    51.38 Billion USD
    Annual Revenue in USD
    19,085 Million USD
    Annual Operating Income in USD
    13,939 Million USD
    Annual Net Income in USD
    10,402 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    BIONTECH SE is biotechnology company with headquarters is in Germany.

  10. Neurocrine Biosciences

    World Rank (Aug-2026)
    1,534
    Market Cap (Aug-2026)
    15.524 Billion USD
    World Rank (Jan-05-2024)
    1,326
    Market Cap (Jan-05-2024)
    13.124 Billion USD
    World Rank (Jul-30-2023)
    1,672
    Market Cap (Jul-30-2023)
    10.026 Billion USD
    World Rank (Dec-25-2022)
    1,362
    Market Cap (Dec-25-2022)
    11.566 Billion USD
    World Rank (Jan-07-2022)
    2,475
    Market Cap (Jan-07-2022)
    7.15 Billion USD
    Annual Revenue in USD
    2,861 Million USD
    Annual Operating Income in USD
    619 Million USD
    Annual Net Income in USD
    479 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Neurocrine Biosciences is a Neuroscience Focused and Biopharmaceutical company. It is discovering and developing life-changing treatments for people with serious, challenging, under addressed neurological, endocrine and psychiatric disorders. The headquarters is in USA.

Share

Ads